Case Study: Novo Nordisk achieves €45M annual savings with Coupa

Novo Nordisk achieves €45M in annual savings with Coupa

Novo Nordisk, a multinational pharmaceutical company, faced challenges with low spend transparency and complex procure-to-pay processes due to multiple point solutions. This complexity led to poor user adoption and saving leakages, hindering their need to digitize sourcing and contract management to reduce risk. To address this, they partnered with Coupa.

Coupa implemented its single suite solution for procure-to-pay, contract management, and invoicing. This provided a holistic view of spend and automated workflows, leading to high user adoption and improved compliance. The results enabled better supplier collaboration, with 99% of sourcing events conducted digitally, and transformed procurement into a value unit. Coupa helped Novo Nordisk achieve €45 million in annual savings, which the company reinvests into life-saving treatment research.

Novo Nordisk